Dr Matthew Buckland

Job title

Consultant immunologist

Qualifications

MBBS 
BSc 
MSc 
PhD 
FRCP 
FRCPath 
DipHIVMed 
PGCAP 
FHEA

GMC Number

4310835

Contact details

Phone number: 020 7794 0500 ext 34906

Email address: mbuckland@nhs.net

Fax: 020 7743 1943

Related services

Immunology

Biography

Dr Buckland is an immunologist with a special interest in diagnostics for rare disorders and the management of children and young adults with primary immunodeficiencies.

Publications

  • Duraisingham SS, Manson A, Grigoriadou S et al. (2015) . Immune deficiency: changing spectrum of pathogens.Clinical & Experimental Immunology vol. 181, (2) 267-274. 10.1111/cei.12600 http://qmro.qmul.ac.uk/xmlui/handle/123456789/6922 
  • White PD, Clark L, Thomas JM et al. (2015) . Case control study of circulating cytokines in chronic fatigue syndrome. JOURNAL OF PSYCHOSOMATIC RESEARCH. vol. 78, 631-631. 10.1016/j.jpsychores.2015.03.139 
  • Longhurst HJ, Yong PF, Manson AL et al. (2015) . Mullins' syndrome: a new gammopathy-related autoinflammatory syndrome resistant to anakinra.QJM vol. 108, (6) 497-501. 10.1093/qjmed/hcs208 http://qmro.qmul.ac.uk/xmlui/handle/123456789/10691 
  • White PD, Blundell L, Ray K et al. (2015) . Systematic review of circulating cytokines in chronic fatigue syndrome. Journal of Psychosomatic Research. vol. 78, 631-631. 10.1016/j.jpsychores.2015.03.140 
  • Adhya Z, Rahman T, Grigoriadou S et al. (2015) . Abnormal V-beta Repertoire: Defining Pre-test Clinical And Laboratory Parameters. Clinical and Experimental Immunology. vol. 182, 12-12. 
  • Hodkinson J, Bangs C, Buckland M et al. (2015) . Does IgA Or IgM Titre Affect Clinical Outcome In Primary Immunodeficiency?. Clinical and Experimental Immunology. vol. 182, 16-17. 
  • Adhya Z, Rahman T, Grigoriadou S et al. (2015) . Euroclass And Transitional B-cells In Common Variable Immune Deficiency: Defining At Risk Populations. Clinical and Experimental Immunology. vol. 182, 12-12. 
  • Edgar JDM, Hollingsworth R, Bangs C et al. (2015) . First Report On Immunoglobulin Usage In The UK Combining Data From The UKPIN Registry And National Immunoglobulin Database. Clinical and Experimental Immunology. vol. 182, 5-6. 
  • Bangs C, Farrell S, Guzman D et al. (2015) . Launch Of The New Design UKPID Registry. Clinical and Experimental Immunology. vol. 182, 10-10. 
  • Walker E, Hickey A, Scott C et al. (2015) . Quantitative And Qualitative Assessment Of Lymphocyte Proliferation By CFSE In Primary Immunodeficiency. Clinical and Experimental Immunology. vol. 182, 31-31. 
  • Longhurst H, Dempster J, Lorenzo L et al. (2015) . Real-World Outcomes In Hereditary Angioedema: Experience From The Icatibant Outcome Survey In The United Kingdom. Clinical and Experimental Immunology. vol. 182, 10-11. 
  • Bangs C, Farrell S, Guzman D et al. (2015) . UKPID Registry: 2015 Update. Clinical and Experimental Immunology. vol. 182, 18-18. 
  • Lock HR, Scott C, Buckland M (2014) . Natalizumab antibodies: 6 year experience of the national reference centre for antibodies to Natalizumab. IMMUNOLOGY. vol. 143, 179-179. 
  • Makatsori M, Kiani-Alikhan S, Manson AL et al. (2014) . Hypogammaglobulinaemia after rituximab treatment-incidence and outcomes.QJM vol. 107, (10) 821-828. 10.1093/qjmed/hcu094 
  • Duraisingham SS, Buckland MS, Dempster J et al. (2014) . Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement. JOURNAL OF CLINICAL IMMUNOLOGY. vol. 34, S290-S291. http://qmro.qmul.ac.uk/xmlui/handle/123456789/7031 
  • Duraisingham S, Dempster J, Lorenzo L et al. (2014) . Subcutaneous Immunoglobin Replacement Therapy - Flexible Dosing. JOURNAL OF CLINICAL IMMUNOLOGY. vol. 34, S290-S290. http://qmro.qmul.ac.uk/xmlui/handle/123456789/7102 
  • Bangs C, Edgar JDM, Guzman D et al. (2014) . UKPID Registry: 2014 Update. JOURNAL OF CLINICAL IMMUNOLOGY. vol. 34, S322-S322. http://qmro.qmul.ac.uk/xmlui/handle/123456789/7104 
  • Hartley AJ, Rajakariar R, Sheaff M et al. (2014) . Syphilis masquerading as focal segmental glomerulosclerosis.Int J STD AIDS vol. 25, (7) 529-531. 10.1177/0956462413516940 
  • Duraisingham SS, Buckland MS, Grigoriadou S et al. (2014) . Secondary antibody deficiency.Expert Rev Clin Immunol vol. 10, (5) 583-591. 10.1586/1744666X.2014.902314 
  • Tohani A, Chua I, Grigoriadou S et al. (2014) . Acquired C1 inhibitor deficiency: should we monitor for associated antibody deficiency?.Ann Allergy Asthma Immunol vol. 112, (3) 265-267. 10.1016/j.anai.2013.12.024 
  • Dorling A, Rebollo-Mesa I, Hilton R et al. (2014) . Can a combined screening/treatment programme prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies: study protocol for the multicentre randomised controlled OuTSMART trial.Trials vol. 15, 10.1186/1745-6215-15-30 http://qmro.qmul.ac.uk/xmlui/handle/123456789/8664 
  • Duraisingham SS, Buckland M, Dempster J et al. (2014) . Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement.PLoS One vol. 9, (6) 10.1371/journal.pone.0100324 http://qmro.qmul.ac.uk/xmlui/handle/123456789/10690 
  • Edgar JDM, Buckland M, Guzman D et al. (2014) . The United Kingdom Primary Immune Deficiency (UKPID) Registry: Report of the first 4 years' activity 2008-2012.Clinical and Experimental Immunology vol. 175, (1) 68-78. 10.1111/cei.12172 
  • Manson AL, Dempster J, Grigoriadou S et al. (2014) . Use of recombinant C1 inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedema.Eur J Dermatol vol. 24, (1) 28-34. 10.1684/ejd.2013.2252 
  • Bangs C, Guzman D, Edgar D et al. (2013) . UKPID registry: December 2013 update. CLINICAL AND EXPERIMENTAL IMMUNOLOGY. vol. 174, 17-17. 
  • Manson AL, Price A, Dempster J et al. (2013) . In pursuit of excellence: an integrated care pathway for C1 inhibitor deficiency.Clin Exp Immunol vol. 173, (1) 1-7. 
  • 10.1111/cei.12083 
  • http://qmro.qmul.ac.uk/xmlui/handle/123456789/11965 
  • Smyth LA, Ratnasothy K, Moreau A et al. (2013) . Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.J Immunol vol. 190, (9) 4848-4860. 10.4049/jimmunol.1200870 
  • Busse PJ, Buckland MS (2013) . Non-histaminergic angioedema: focus on bradykinin-mediated angioedema.CLINICAL AND EXPERIMENTAL ALLERGY vol. 43, (4) 385-394. 10.1111/cea.12019 
  • Bright P, Grigoriadou S, Kamperidis P et al. (2013) . Changes in B cell immunophenotype in common variable immunodeficiency: cause or effect - is bronchiectasis indicative of undiagnosed immunodeficiency?.Clin Exp Immunol vol. 171, (2) 195-200. 10.1111/cei.12010 
  • BUCKLAND MS (2013) . The Immunological Barriers to Regenerative Medicine.The Immunological Barriers to Regenerative Medicine, Editors: Fairchild, PJ, Springer
  • Makatsori M, Manson AL, Verma N et al. (2012) . POST-RITUXIMAB PROLONGED HYPOGAMMAGLOBULINEMIA REQUIRING INTRAVENOUS IMMUNOGLOBULIN REPLACEMENT THERAPY (IVIG). JOURNAL OF CLINICAL IMMUNOLOGY. vol. 32, 283-283. 
  • Buckland MS, Bangs C, Edgar DE et al. (2012) . THE UKPIN PRIMARY IMMUNODEFICIENCY (PID) REGISTRY: 2012 UPDATE. JOURNAL OF CLINICAL IMMUNOLOGY. vol. 32, 239-239. 
  • Clark L, Buckland M, Vleck V et al. (2012) . Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: Proof of principle study. JOURNAL OF PSYCHOSOMATIC RESEARCH. vol. 72, 475-475. 10.1016/j.jpsychores.2012.03.004 
  • Buckland M (2012) . Immunodeficiency: updating the personalized medicine approach to diagnostics and therapeutics.Expert Rev Clin Immunol vol. 8, (3) 223-225. 10.1586/eci.12.4 
  • Dorward J, Garrett N, Scott D et al. (2011) . Successful treatment of acute hepatitis C virus in HIV positive patients using the European AIDS Treatment Network guidelines for treatment duration.J Clin Virol vol. 52, (4) 367-369. 10.1016/j.jcv.2011.08.020 
  • Dua J, Longhurst H, Bright P et al. (2011) . Pyoderma gangrenosum-like ulcer caused by Helicobacter cinaedi in a patient with X-linked agammaglobulinaemia. BRITISH JOURNAL OF DERMATOLOGY. vol. 165, 12-13. 10.1111/j.1365-2230.2011.04293.x 
  • Dhairyawan R, Harrison R, Buckland M et al. (2011) . Hereditary angioedema: an unusual cause of genital swelling presenting to a genitourinary medicine clinic.Int J STD AIDS vol. 22, (6) 356-357. 10.1258/ijsa.2011.010401 
  • Dorward J, Garrett N, Scott D et al. (2011) . Successful treatment of acute hepatitis C virus in a cohort of HIV-positive patients. HIV MEDICINE. vol. 12, 43-43. 
  • Van Kooten C, Lombardi G, Gelderman KA et al. (2011) . Dendritic cells as a tool to induce transplantation tolerance: Obstacles and opportunities.Transplantation vol. 91, (1) 2-7. 10.1097/TP.0b013e31820263b3 
  • Woodbine L, Grigoriadou S, Goodarzi AA et al. (2010) . An Artemis polymorphic variant reduces Artemis activity and confers cellular radiosensitivity.DNA REPAIR vol. 9, (9) 1003 1010. 10.1016/j.dnarep.2010.07.001 
  • Golshayan D, Wyss JC, Buckland M et al. (2010) . Differential role of naïve and memory CD4<sup>+</sup> T-cell subsets in primary alloresponses.American Journal of Transplantation vol. 10, (8) 1749-1759. 10.1111/j.1600-6143.2010.03180.x 
  • BUCKLAND MS (2009) . Dendritic cells.Dendritic cells, Editors: Adorini, L, Lombardi, G, Vasquez, YR, Springer
  • Buckland M, Ali R, Bothamley G et al. (2009) . Recurrent mycobacterial infections in a patient with IL-12 deficiency.BMJ Case Rep vol. 2009, 10.1136/bcr.11.2008.1278 
  • Grigoriadou S, Walker E, Woodbine L et al. (2008) . Leaky ARTEMIS mutation with an unusual fungal infection.CLINICAL AND EXPERIMENTAL IMMUNOLOGY vol. 154, 29-30. 
  • Buckland M, Jago C, Fazekesova H et al. (2006) . Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cells.Int Immunopharmacol vol. 6, (13-14) 1895-1901. 10.1016/j.intimp.2006.07.008 
  • Buckland M, Jago C, Fazekesova H et al. (2006) . Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cells.International Immunopharmacology vol. 6, (11) 1729-1735. 10.1016/j.intimp.2006.08.004 
  • List J, Buckland MS, Thobhani B et al. (2006) . Dark immunofluorescence: Correlation with serum immunoglobulin abnormalities.CLIN VACCINE IMMUNOL vol. 13, (11) 1294-1295. 10.1128/CVI.00218-06 
  • Buckland M, Jago CB, Fazekasova H et al. (2006) . Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells.Am J Transplant vol. 6, (9) 2046-2059. 10.1111/j.1600-6143.2006.01450.x 
  • Buckland MS, Mylonaki M, Rampton D et al. (2005) . Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.Clin Diagn Lab Immunol vol. 12, (11) 1328-1330. 10.1128/CDLI.12.11.1328-1330.2005 
  • White PD, Nye KE, Pinching AJ et al. (2004) . Immunological changes after both exercise and activity in chronic fatigue syndrome: A pilot study.Journal of Chronic Fatigue Syndrome vol. 12, (2) 51-66. 10.1300/J092v12n02_06 
  • Buckland MS, Pinching AJ (2004) . Immunology of HIV--filling in the details.Int J STD AIDS vol. 15, (9) 574-583. 10.1258/0956462041724217 
  • Buckland MS, Longhurst HI, Murphy M (2004) . Osteomyelitis complicating pyomyositis in HIV disease.INT J STD AIDS vol. 15, (9) 632-634.10.1258/0956462041724226 
  • Sewell WAC, Buckland MS, Jolles SRA (2003) . Therapeutic strategies in common variable immunodeficiency.DRUGS vol. 63, (13) 1359-1371.10.2165/00003495-200363130-00003 
  • Buckland M, Mylonaki M, Rampton DS et al. (2002) . ASCA and ANCA in the diagnosis of inflammatory bowel disease and other diarrhoeal illnesses. GUT. vol. 50, A67-A68. 
  • Buckland MS, O'Grady C, Helbert MR (2002) . Infliximab in the treatment of soft tissue inflammation of Behçet's disease.CPD Bulletin Immunology and Allergy vol. 2, (2) 55-57. 
  • Buckland MS, Longhurst HJ (2002) . What blood tests can tell us in people with asthma and related allergic and respiratory disorders.Asthma Journal vol. 7, (1) 21-26.